31 March 2020
1. Market developments and outlook:
Following an initial bounce after the Federal Reserve (the Fed) and US Congress took positive steps towards supporting markets and the US economy, joining a number of other countries in providing significant support, the market appeared to run out of steam – at least for the short term. Global equities were flat over the past two weeks while credit markets gained following one of the most challenging months for credit investors ever. Presently, we see the most opportunity in credit markets – particularly investment grade credit which is favoured by the Fed in their corporate debt purchases and should weather any recession better than lower quality fixed income – and have been tilting the portfolio in credit’s favour over global equities and duration.
Despite some positive developments on the policy front and easing in market turbulence we think it is too early to assume we are out of the woods. Our expectation is that volatility remains as the fallout of the virus spread begins to show up in economic data and corporate earnings. During this period we intend to remain conservatively positioned to help protect client capital and our defensive posture as seen below in section 2 which should be beneficial in mitigating any further weakness. Conversely, if we do gain better visibility on the impact of the crisis or see some stability in global infections, and if markets stabilize, our investment process should also adapt quickly. When it arrives, we expect the recovery in financial markets to be swift and steep due to the extent of monetary and fiscal support currently provided by governments and central banks – even if the real economy takes a little longer. It is worth highlighting the highly dynamic nature of UIFT. Similar to the rapid reduction in risk as the crisis grew, we can equally re-risk by increasing our risk exposures to equities and credits as the crisis shows signs of receding.
2. Performance attribution and positioning:
As of 31 March 2020 | Portfolio Positioning | Contribution to Returns (gross in USD) | ||
Portfolio Exposure | Market Exposure | Contribution to Duration (Years) |
March 2020 | Year-to-Date |
Global Research Income | 8.6% | 0.00 | -0.80% | -1.79% |
Global Income Low Volatility | 26.0% | 0.00 | -6.08% | -10.07% |
Equity Hedging | -20.5% | 0.00 | 2.50% | 3.80% |
Equity Total | 14.1% | 0.00 | -4.38% | -8.05% |
Systematic Fixed Income | 35.2% | 3.77 | -2.93% | -1.93% |
Government bonds | -7.2% | -0.92 | -0.62% | -0.52% |
Systematic US Corporates | 7.7% | 0.53 | -0.94% | -0.69% |
Cash Equivalents | 1.5% | 0.00 | 0.00% | 0.01% |
Credit Hedging | -4.9% | 0.00 | -0.17% | -0.14% |
Fixed Income Total | 32.3% | 3.38 | -4.66% | -3.27% |
European Financials | 6.8% | 0.21 | -0.70% | -0.69% |
Global Property | 4.7% | 0.00 | -0.73% | -1.27% |
Alternatives Total | 11.5% | 0.21 | -1.43% | -1.97% |
Total | 57.9% | 3.59 | -10.47% | -13.30% |
3. Recent portfolio positioning and key changes:
Over the past week we made three key adjustments to portfolio positioning:
All information in this publication is based upon certain assumptions and analysis of information available as at the date of the publication and reflects prevailing conditions and UOB Asset Management Ltd (“UOBAM”)’s views as of such date, all of which are subject to change at any time without notice. Although care has been taken to ensure the accuracy of information contained in this publication, UOBAM makes no representation or warranty of any kind, express, implied or statutory, and shall not be responsible or liable for the accuracy or completeness of the information.
Potential investors should read the prospectus of the fund(s) (the “Fund(s)”) which is available and may be obtained from UOBAM or any of its appointed distributors, before deciding whether to subscribe for or purchase units in the Fund(s). Returns on the units are not guaranteed. The value of the units and the income from them, if any, may fall as well as rise. Please note that the graphs, charts, formulae or other devices set out or referred to in this document cannot, in and of itself, be used to determine and will not assist any person in deciding which investment product to buy or sell, or when to buy or sell an investment product. An investment in the Fund(s) is subject to investment risks and foreign exchange risks, including the possible loss of the principal amount invested. Investors should consider carefully the risks of investing in the Fund(s) and may wish to seek advice from a financial adviser before making a commitment to invest in the Fund(s). Should you choose not to seek advice from a financial adviser, you should consider carefully whether the Fund(s) is suitable for you. Investors should note that the past performance of any investment product, manager, company, entity or UOBAM mentioned in this publication, and any prediction, projection or forecast on the economy, stock market, bond market or the economic trends of the markets is not necessarily indicative of the future or likely performance of any investment product, manager, company, entity or UOBAM or the economy, stock market, bond market or economic trends of the markets. Nothing in this publication shall constitute a continuing representation or give rise to any implication that there has not been or that there will not be any change affecting the Funds. All subscription for the units in the Fund(s) must be made on the application forms accompanying the prospectus of that fund.
The above information is strictly for general information only and is not an offer, solicitation advice or recommendation to buy or sell any investment product or invest in any company. This publication should not be construed as accounting, legal, regulatory, tax, financial or other advice. Investments in unit trusts are not obligations of, deposits in, or guaranteed or insured by United Overseas Bank Limited, UOBAM, or any of their subsidiary, associate or affiliate or their distributors. The Fund(s) may use or invest in financial derivative instruments and you should be aware of the risks associated with investments in financial derivative instruments which are described in the Fund(s)’ prospectus. In the event of any discrepancy between the English and Mandarin versions of this publication, the English version shall prevail. This advertisement or publication has not been reviewed by the Monetary Authority of Singapore.